These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12018664)

  • 1. Glucose tolerance and cardiovascular risk in young adult African Americans.
    Campbell KL; Borde-Perry WC; Murtaugh KH; Gidding SS; Falkner B
    Am J Med Sci; 2002 May; 323(5):231-7. PubMed ID: 12018664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.
    Gaillard TR; Schuster DP; Bossetti BM; Green PA; Osei K
    Diabetes Care; 1997 May; 20(5):745-52. PubMed ID: 9135936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can cardiovascular risk be predicted by newborn, childhood, and adolescent body size? An examination of longitudinal data in urban African Americans.
    Hulman S; Kushner H; Katz S; Falkner B
    J Pediatr; 1998 Jan; 132(1):90-7. PubMed ID: 9470007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance predicts future deterioration of glucose tolerance in nondiabetic young African Americans.
    Huan Y; Falkner B
    Metabolism; 2009 May; 58(5):689-95. PubMed ID: 19375593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.
    Osei K; Gaillard T; Schuster D
    Obes Res; 2005 Jan; 13(1):179-85. PubMed ID: 15761178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention.
    Osei K; Rhinesmith S; Gaillard T; Schuster D
    Diabetes Care; 2004 Jun; 27(6):1439-46. PubMed ID: 15161801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancies in the regulation of plasma adiponectin and TNF-alpha levels and adipose tissue gene expression in obese African Americans with glucose intolerance: a pilot study using rosiglitazone.
    Osei K; Gaillard T; Cook C; Kaplow J; Bullock M; Schuster D
    Ethn Dis; 2005; 15(4):641-8. PubMed ID: 16259488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study.
    Karter AJ; Mayer-Davis EJ; Selby JV; D'Agostino RB; Haffner SM; Sholinsky P; Bergman R; Saad MF; Hamman RF
    Diabetes; 1996 Nov; 45(11):1547-55. PubMed ID: 8866560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.
    Osei K; Gaillard T; Schuster D
    Metabolism; 2007 Jan; 56(1):24-9. PubMed ID: 17161222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, smoking, and multiple cardiovascular risk factors in young adult African Americans.
    Murtaugh KH; Borde-Perry WC; Campbell KL; Gidding SS; Falkner B
    Ethn Dis; 2002; 12(3):331-5. PubMed ID: 12148703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.
    Osei K; Gaillard T; Schuster DP
    Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose.
    Liao D; Shofer JB; Boyko EJ; McNeely MJ; Leonetti DL; Kahn SE; Fujimoto WY
    Diabetes Care; 2001 Jan; 24(1):39-44. PubMed ID: 11194238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased insulin-mediated but not non-insulin-dependent glucose disposal rates in glucose intolerance and type II diabetes in African (Ghanaian) immigrants.
    Osei K; Schuster DP
    Am J Med Sci; 1996 Mar; 311(3):113-21. PubMed ID: 8615385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of oral glucose tolerance test-derived estimates of insulin sensitivity with insulin clamp measurements in an African-American cohort.
    Cheng C; Campbell KL; Kushner H; Falkner BE
    Metabolism; 2004 Sep; 53(9):1107-12. PubMed ID: 15334368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action.
    Osei K; Rhinesmith S; Gaillard T; Schuster D
    Metabolism; 2003 May; 52(5):565-72. PubMed ID: 12759885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of metabolically unhealthy overweight/obese African American women: significance of insulin-sensitive and insulin-resistant phenotypes.
    Gaillard TR; Schuster D; Osei K
    J Natl Med Assoc; 2012; 104(3-4):164-71. PubMed ID: 22774383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in cardiovascular risk factors in obese, nondiabetic first degree relatives of African Americans with type 2 diabetes mellitus.
    Gaillard TR; Schuster DP; Osei K
    Ethn Dis; 1998; 8(3):319-30. PubMed ID: 9926902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions.
    Sumner AE; Kushner H; Sherif KD; Tulenko TN; Falkner B; Marsh JB
    Diabetes Care; 1999 Jan; 22(1):71-7. PubMed ID: 10333906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.